Veículo
The Eagle-Tribune (EUA)
Em 2024: 1 notícias
Desde 1995: 4 notícias
Your morning coffee may be more than a half million years old
Publicado em 15 abril 2024
That coffee you slurped this morning? It’s 600,000 years old.
Using genes from coffee plants around the world, researchers built a family tree for the world’s most popular type of coffee, known to scientists as Coffea arabica and to coffee lovers simply as “arabica.”
The researchers, hoping to learn more about the plants to better protect them from pests and climate change, found that the species emerged around 600,000 years ago through natural crossbreeding of two [...]
-
Foresee Pharmaceuticals Announces Publication of Preclinical Data in the European Heart Journal Demonstrating the Therapeutic Potential of Foresee ALDH2 Activators in the Treatment of Heart Failure and Further Elucidating a Novel Mechanism of Action
Publicado em 08 novembro 2023TAIPEI, Nov. 8, 2023 /PRNewswire/ -- Foresee Pharmaceuticals (TPEx: 6576), ("Foresee") announced today preclinical data in the European Heart Journal, demonstrating that activation of Aldehyde Dehydrogenase 2 (ALDH2) with Foresee's oral ALDH2 activator AD-9308, significantly ameliorates heart failure via the modulation of the Dicer-miRNA pathway in the heart. The article is cited "Kiyuna L, Candido D, Bechara L, Jesus I, Ramalho L, Krum B, et al. 4-hydroxynonenal impairs [...]ver notícia -
$205 Million Investment Accelerates Construction of the Giant Magellan Telescope
Publicado em 02 agosto 2022PASADENA, Calif., Aug. 02, 2022 (GLOBE NEWSWIRE) -- The Giant Magellan Telescope, the most powerful telescope ever engineered using the world’s largest mirrors, today announced it has secured a $205 million investment from its international consortium to accelerate construction. This investment marks one of the largest funding rounds for the telescope since its founding and includes leading commitments from the Carnegie Institution for Science, Harvard University, the São Paulo [...]ver notícia -
Blue Water Vaccines Announces Collaboration with Instituto Butantan for the Development of BWV-101, a Universal Influenza Vaccine Candidate
Publicado em 19 maio 2022CINCINNATI, May 19, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines, Inc. (“BWV” or “Blue Water Vaccines” or “the Company”) a biopharmaceutical company developing vaccines, announces a collaboration with the multidisciplinary Center for R&D in Immunobiologics (“CeRDI”), an initiative of Instituto Butantan (“Butantan”). Through this partnership, Butantan, a leading Brazilian producer of immunobiologic products and vaccines, and BWV [...]ver notícia